Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting
29 nov. 2022 09h00 HE | InSilico Medicine
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the  41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
J.P. Morgan Private Bank to be Presenting Sponsor for the Audrain Tour d’Elegance
05 août 2022 15h52 HE | Audrain Concours Foundation
Newport, Rhode Island, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The Audrain Newport Concours & Motor Week is pleased to announce that J.P. Morgan Private Bank has secured the exclusive naming rights as...
Financial Solutions Lab Announces 2022 Accelerator Cohort Focused on Access and Removing Systemic Barriers to Financial Benefits & Tools for Underserved Consumers
03 mai 2022 08h00 HE | Financial Health Network
Chicago, IL, May 03, 2022 (GLOBE NEWSWIRE) -- The Financial Solutions Lab, an initiative launched and managed by the Financial Health Network in collaboration with founding partner JPMorgan Chase...
Abel Noser Solutions Teams Up With Neovest to Provide Reporting Options for Traders, Managers and Brokers
29 mars 2022 06h30 HE | Abel Noser Solutions
New York, NY, March 29, 2022 (GLOBE NEWSWIRE) -- Abel Noser Solutions announced today that Abel Noser has teamed up with Neovest to create a specialized analytics reporting offering for clients and...
RevolutionLogo.png
Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference
11 janv. 2022 14h15 HE | Revolution Medicines, Inc.
RAS(ON) Inhibitor Pipeline Expands with Advancement of Two New Drug Candidates; Development-Stage Portfolio Covers RAS Drivers of Majority of RAS-Addicted Cancers First Patient Dosed in Global Phase...
logo.jpg
ImCheck to Present at 40th Annual J.P. Morgan Healthcare Conference
06 janv. 2022 06h00 HE | ImCheck Therapeutics SAS
ImCheck to Present at 40th Annual J.P. Morgan Healthcare Conference         Marseille, France, January 6, 2022 – ImCheck Therapeutics announced today that its Chief Executive Officer, Pierre...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Virtual 40th Annual J.P. Morgan Healthcare Conference
04 janv. 2022 16h15 HE | Mettler-Toledo, LLC
Columbus, OH, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Virtual 40th Annual J.P. Morgan Healthcare...
RevolutionLogo.png
Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference
04 janv. 2022 07h30 HE | Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies for RAS-addicted...
KT graphic BLUE.png
ATTENTION NORTHSTAR FINANCIAL SERVICES (BERMUDA) INVESTORS: The Securities Arbitration Law Firm of KlaymanToskes Commences Investigation of Potential Claims on Behalf of J.P. MORGAN SECURITIES CUSTOMERS
02 août 2021 16h58 HE | Klayman & Toskes P.A.
MIAMI, Aug. 02, 2021 (GLOBE NEWSWIRE) --  National investor fraud law firm, KlaymanToskes (“KT”), has commenced an investigation of potential FINRA arbitration claims on behalf of investors who...
PECOHorizontalLogoBlue.png
Phillips Edison & Company Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
02 août 2021 16h15 HE | Phillips Edison & Company, Inc.
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of omni-channel grocery-anchored...